Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen

Andrew J. Poole(Immunocore (United States)), Chandramouli Chillakuri(Immunocore (United States))
Nature Communications
September 10, 2022
Cited by 100


Related Papers

No related papers found

Powered by citation graph analysis